Microbial influence on blood pressure: unraveling the complex relationship for health insights

Abstract

Hypertension, a critical global health concern, is characterized by persistent high blood pressure and is a major cause of cardiovascular events. This perspective explores the multifaceted implications of hypertension, its association with cardiovascular diseases, and the emerging role of the gut microbiota. The gut microbiota, a dynamic community in the gastrointestinal tract, plays a pivotal role in hypertension by influencing blood pressure through the generation of antioxidant, anti-inflammatory, and short-chain fatty acids metabolites, and the conversion of nitrates into nitric oxide. Antihypertensive medications interact with the gut microbiota, impacting drug pharmacokinetics and efficacy. Prebiotics and probiotics present promising avenues for hypertension management, with prebiotics modulating blood pressure through lipid and cholesterol modulation, and probiotics exhibiting a general beneficial effect. Personalized choices based on individual factors are crucial for optimizing prebiotic and probiotic interventions. In conclusion, the gut microbiota’s intricate influence on blood pressure regulation offers innovative perspectives in hypertension therapeutics, with targeted strategies proving valuable for holistic blood pressure management and health promotion.

Keywords

Cardiovascular risk / gut microbiota / hypertension / lactobacillus / machine learning / microbiome-host interactions

References

[1] Leow MK.Environmental origins of hypertension: phylogeny, ontogeny and epigenetics.Hypertens Res2015;38:299-307

[2] Beevers G,O’Brien E.ABC of hypertension: the pathophysiology of hypertension.BMJ2001;322:912-6 PMCID:PMC1120075

[3] Brook RD.The environment and blood pressure.Cardiol Clin2017;35:213-21

[4] Kjeldsen SE.Hypertension and cardiovascular risk: general aspects.Pharmacol Res2018;129:95-9

[5] Fuchs FD.High blood pressure and cardiovascular disease.Hypertension2020;75:285-92 PMCID:PMC10243231

[6] Roth GA,Johnson CO.GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing GroupGlobal burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study.J Am Coll Cardiol2020;76:2982-3021 PMCID:PMC7755038

[7] Kamali Z,Haghjooy Javanmard S.Large-scale multi-omics studies provide new insights into blood pressure regulation.Int J Mol Sci2022;23:7557 PMCID:PMC9323755

[8] Dinakis E,Gill P.Association between the gut microbiome and their metabolites with human blood pressure variability.Hypertension2022;79:1690-701

[9] Adua E.Decoding the mechanism of hypertension through multiomics profiling.J Hum Hypertens2023;37:253-64 PMCID:PMC10063442

[10] Currie G.The future of “omics” in hypertension.Can J Cardiol2017;33:601-10 PMCID:PMC5417769

[11] Nitzan M.Feasibility of precision medicine in hypertension management-scope and technological aspects.J Pers Med2022;12:1861 PMCID:PMC9698650

[12] Linares DM,Stanton C.Beneficial microbes: the pharmacy in the gut.Bioengineered2016;7:11-20 PMCID:PMC4878258

[13] Eloe-Fadrosh EA.The human microbiome: from symbiosis to pathogenesis.Annu Rev Med2013;64:145-63 PMCID:PMC3731629

[14] Sudhakar P,Verstockt B,Vermeire S.Computational biology and machine learning approaches to understand mechanistic microbiome-host interactions.Front Microbiol2021;12:618856 PMCID:PMC8148342

[15] Grazioli F,Alqassem I,Pileggi G.Microbiome-based disease prediction with multimodal variational information bottlenecks.PLoS Comput Biol2022;18:e1010050 PMCID:PMC9022840

[16] Palmu J,Niiranen T.Targeting gut microbiota to treat hypertension: a systematic review.Int J Environ Res Public Health2021;18:1248 PMCID:PMC7908114

[17] Aryal S,Mei X.Combating hypertension beyond GWAS: microbiome and artificial intelligence as opportunities for precision medicine.Camb Prisms Precis Med2023;1:e26

[18] Nakai M,Stevens BR.Essential hypertension is associated with changes in gut microbial metabolic pathways: a multisite analysis of ambulatory blood pressure.Hypertension2021;78:804-15

[19] Pontarollo G,Mann A.Commensal bacteria weaken the intestinal barrier by suppressing epithelial neuropilin-1 and Hedgehog signaling.Nat Metab2023;5:1174-87 PMCID:PMC10365997

[20] Lecuit M.Chapter 21 - The viruses of the gut microbiota. In: The microbiota in gastrointestinal pathophysiology. Elsevier; 2017. pp. 179-83.

[21] Thursby E.Introduction to the human gut microbiota.Biochem J2017;474:1823-36 PMCID:PMC5433529

[22] Beam A,Hao L.Effect of diet and dietary components on the composition of the gut microbiota.Nutrients2021;13:2795 PMCID:PMC8398149

[23] Valdes AM,Segal E.Role of the gut microbiota in nutrition and health.BMJ2018;361:k2179 PMCID:PMC6000740

[24] Guinane CM.Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ.Therap Adv Gastroenterol2013;6:295-308 PMCID:PMC3667473

[25] Jandhyala SM,Subramanyam C,Sasikala M.Role of the normal gut microbiota.World J Gastroenterol2015;21:8787-803 PMCID:PMC4528021

[26] Wu Y,Tu X.The role of short-chain fatty acids of gut microbiota origin in hypertension.Front Microbiol2021;12:730809 PMCID:PMC8506212

[27] Chen XF,Tang G,Chen X.Short-chain fatty acids in blood pressure, friend or foe.Chin Med J2021;134:2393-4 PMCID:PMC8509914

[28] Miyamoto J,Nakajima A,Itoh H.The role of short-chain fatty acid on blood pressure regulation.Curr Opin Nephrol Hypertens2016;25:379-83

[29] Huynh K.Microbial metabolites reduce SBP in patients with resistant hypertension.Nat Rev Cardiol2023;20:140

[30] Deng W,Du Q.The association of serum total bile acid with new-onset hypertension during pregnancy.BMC Pregnancy Childbirth2022;22:879 PMCID:PMC9701419

[31] Arab J, Barrera F, Arrese M. Bile acids and portal hypertension.Ann Hepatol2017;16:S83-6

[32] O’Donnell JA,Meric G.The gut microbiome and hypertension.Nat Rev Nephrol2023;19:153-67

[33] Avery EG,Maifeld A.The gut microbiome in hypertension: recent advances and future perspectives.Circ Res2021;128:934-50

[34] Yan D,Zhou X.Regulatory effect of gut microbes on blood pressure.Animal Model Exp Med2022;5:513-31 PMCID:PMC9773315

[35] Jose PA.Gut microbiota in hypertension.Curr Opin Nephrol Hypertens2015;24:403-9 PMCID:PMC4578629

[36] Song JS,Yoon SM,Ki C.The association between gut microbiome and hypertension varies according to enterotypes: a Korean study.Front Microbiomes2023;2:1072059

[37] Zhang Y,Ma D.Probiotics Bifidobacterium lactis M8 and Lactobacillus rhamnosus M9 prevent high blood pressure via modulating the gut microbiota composition and host metabolic products.mSystems2023;8:e0033123 PMCID:PMC10734487

[38] Cookson TA.Bacterial-induced blood pressure reduction: mechanisms for the treatment of hypertension via the gut.Front Cardiovasc Med2021;8:721393 PMCID:PMC8414577

[39] Hoyles L,Chilloux J.Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota.Microbiome2018;6:73 PMCID:PMC5909246

[40] Shanmugham M,Leo CH.Gut-derived metabolite, trimethylamine-N-oxide (TMAO) in cardio-metabolic diseases: detection, mechanism, and potential therapeutics.Pharmaceuticals2023;16:504 PMCID:PMC10142468

[41] Huang R,Lei Y.The gut microbial-derived metabolite trimethylamine N-oxide and atrial fibrillation: relationships, mechanisms, and therapeutic strategies.Clin Interv Aging2021;16:1975-86 PMCID:PMC8643130

[42] Yang S,Yang F.Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target.Front Pharmacol2019;10:1360 PMCID:PMC6877687

[43] Khodor S, Reichert B, Shatat IF. The microbiome and blood pressure: can microbes regulate our blood pressure?.Front Pediatr2017;5:138 PMCID:PMC5474689

[44] Masenga SK,Hangoma J.Recent advances in modulation of cardiovascular diseases by the gut microbiota.J Hum Hypertens2022;36:952-9 PMCID:PMC9649420

[45] Jama HA,Marques FZ.The gut microbiota and blood pressure in experimental models.Curr Opin Nephrol Hypertens2019;28:97-104

[46] Joe B,Edwards JM.Microbiota introduced to germ-free rats restores vascular contractility and blood pressure.Hypertension2020;76:1847-55 PMCID:PMC7666075

[47] Zheng D,Elinav E.Interaction between microbiota and immunity in health and disease.Cell Res2020;30:492-506 PMCID:PMC7264227

[48] Krzemińska J,Młynarska E,Rysz J.Arterial hypertension-oxidative stress and inflammation.Antioxidants2022;11:172 PMCID:PMC8772909

[49] Ghatage T,Dhar A.Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies.Hypertens Res2021;44:740-55 PMCID:PMC7967108

[50] Prado NJ,Mazzei L.Anti-inflammatory, antioxidant, antihypertensive, and antiarrhythmic effect of indole-3-carbinol, a phytochemical derived from cruciferous vegetables.Heliyon2022;8:e08989 PMCID:PMC8866897

[51] Tokarek J,Saar M.Does the composition of gut microbiota affect hypertension? Molecular mechanisms involved in increasing blood pressure.Int J Mol Sci2023;24:1377 PMCID:PMC9863380

[52] Sun D,Yan J.Intestinal microbiota: a promising therapeutic target for hypertension.Front Cardiovasc Med2022;9:970036 PMCID:PMC9705378

[53] Caspani G,Foster JA.Gut microbial metabolites in depression: understanding the biochemical mechanisms.Microb Cell2019;6:454-81 PMCID:PMC6780009

[54] Parker A,Carding SR.Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health.Gut Microbes2020;11:135-57 PMCID:PMC7053956

[55] Zheng T.Gut microbiota: friends or foes for blood pressure-lowering drugs.Hypertension2022;79:1602-4

[56] Chen HQ,Xing K,Ren H.Pharmacomicrobiomics: exploiting the drug-microbiota interactions in antihypertensive treatment.Front Med2021;8:742394 PMCID:PMC8808336

[57] Faselis C,Papademetriou V.Common secondary causes of resistant hypertension and rational for treatment.Int J Hypertens2011;2011:236239 PMCID:PMC3057025

[58] Kyoung J,Yang T.Resistance to antihypertensive drugs: is gut microbiota the missing link?.Hypertension2022;79:2138-47

[59] Choi MS,Yoo HH.The role of gut microbiota in the pharmacokinetics of antihypertensive drugs.Pharmacol Res2018;130:164-71

[60] Qi Y,Rodriguez V,Pepine CJ.Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension - a case report.Int J Cardiol2015;201:157-8 PMCID:PMC4711349

[61] Robles-Vera I,de la Visitación N.Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects.Br J Pharmacol2020;177:2006-23 PMCID:PMC7161554

[62] Karbach SH,Brandão I.Gut microbiota promote angiotensin II-induced arterial hypertension and vascular dysfunction.J Am Heart Assoc2016;5:e003698 PMCID:PMC5079031

[63] Yang T,Lobaton GO.Sustained captopril-induced reduction in blood pressure is associated with alterations in gut-brain axis in the spontaneously hypertensive rat.J Am Heart Assoc2019;8:e010721 PMCID:PMC6405665

[64] Brocker CN,Flaten HK.Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites.Hum Genomics2020;14:10 PMCID:PMC7066769

[65] Konop M,Grochowska M,Samborowska E.Enalapril decreases rat plasma concentration of TMAO, a gut bacteria-derived cardiovascular marker.Biomarkers2018;23:380-5

[66] Unger T,Charchar F.2020 international society of hypertension global hypertension practice guidelines.Hypertension2020;75:1334-57

[67] Davani-Davari D,Karimzadeh I.Prebiotics: definition, types, sources, mechanisms, and clinical applications.Foods2019;8:92 PMCID:PMC6463098

[68] Jama HA,Nakai M.Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial.Nat Cardiovasc Res2023;2:35-43

[69] Streppel MT,van ’t Veer P,Geleijnse JM.Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials.Arch Intern Med2005;165:150-6

[70] Ansari F,Pourjafar H,Samakkhah SA.The role of probiotics and prebiotics in modulating of the gut-brain axis.Front Nutr2023;10:1173660 PMCID:PMC10410452

[71] Khalesi S,Buys N.Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials.Hypertension2014;64:897-903

[72] Qi D,Zhang JJ.The effect of probiotics supplementation on blood pressure: a systemic review and meta-analysis.Lipids Health Dis2020;19:79 PMCID:PMC7183137

[73] Cardoso AM.Can changes in gut microbiota predict progression toward diabetes?.J Explor Res Pharmacol2021;6:168-9

[74] Lagoumintzis G.Triangulating nutrigenomics, metabolomics and microbiomics toward personalized nutrition and healthy living.Hum Genomics2023;17:109 PMCID:PMC10704648